Wanted Franchise or PCD Distributors for pharma company from Manipur
Wanted Franchise Distributors for pharma company for Manipur State
Following are the districts vacant for franchise from Manipur
Following are the districts vacant for franchise from Manipur
| Bishnupur District |
| Churachandpur District |
| Chandel District |
| Imphal East District |
| Senapati District |
| Tamenglong District |
| Thoubal District |
| Ukhrul District |
Wanted Franchise or PCD Distributors for pharma company from Assam
Wanted Franchise Distributors for pharma company from Assam
Following are the districts vacant for franchise from Assam
Following are the districts vacant for franchise from Assam
| Tinsukia |
| Dibrugarh |
| Sibsagar |
| Dhemaji |
| Jorhat |
| Lakhimpur |
| Golaghat |
| Sonitpur |
| Karbi Anglong |
| Nagaon |
| Marigaon |
| Darrang |
| Kamrup |
| Nalbari |
| Barpeta |
| Bongaigaon |
| Goalpara |
| Kokrajhar |
| Dhubri |
| North Cachar Hills |
| Cachar |
| Hailakandi |
| Karimganj |
| Kamrup Metropolitan |
| Baksa |
| Udalguri |
| Chirang. |
Wanted Franchise or PCD Distributors for pharma company from Chhattisgarh
Wanted Franchise Distributors for pharma company from Chhattisgarh
Following are the districts vacant for franchise from Chhattisgarh
Following are the districts vacant for franchise from Chhattisgarh
| Bastar |
| Bilaspur |
| Dantewada (South Bastar) |
| Dhamtari |
| Durg |
| Janjgir-Champa |
| Jashpur |
| Kanker (North Bastar) |
| Kawardha |
| Korba |
| Koriya |
| Mahasamund |
| Raigarh |
| Raipur |
| Rajnandgaon |
| Sarguja |
| Narayanpur |
Wanted Franchise or PCD Distributors for pharma company from Jharkhand
Activa Lifesciences offers franchise for the districts of Jharkhand.
Interested Distributors, Stockist, those who want to start their own business can contact us.
Following are the districts from Jharkhand are vacant for franchise
Interested Distributors, Stockist, those who want to start their own business can contact us.
Following are the districts from Jharkhand are vacant for franchise
| Ranchi |
| Lohardaga |
| Gumla |
| Simdega |
| Palamu |
| Latehar |
| Garhwa |
| West Singhbhum |
| Saraikela Kharsawan |
| East Singhbhum |
| Dumka |
| Jamtara |
| Sahebganj |
| Pakur |
| Godda |
| Hazaribagh |
| Chatra |
| Koderma |
| Dhanbad |
| Bokaro |
| Deoghar |
| Khunti |
| Ramgarh |
Wanted Franchise or PCD Distributors for pharma company from Tamil Nadu
Wanted Franchise Distributors for pharma company from Tamil Nadu
Following are the districts vacant for franchise from Tamil Nadu
Following are the districts vacant for franchise from Tamil Nadu
| Ariyalur |
| Chennai |
| Coimbatore |
| Cuddalore |
| Dharmapuri |
| Erode |
| Karur |
| Krishnagiri |
| Madurai |
| Nagapattinam |
| Namakkal |
| Nilgiris |
| Perambalur |
| Pudukkottai |
| Ramanathapuram |
| Salem |
| Sivagangai |
| Thanjavur |
| Thoothukudi |
| Tiruchirappalli |
| Thirunelveli |
| Tirupur |
| Thiruvallur |
| Thiruvannamalai |
| Tiruvarur |
| Vellore |
| Villupuram |
| Virudhunagar |
Wanted Franchise or PCD Distributors for pharma company from Madhya Pradesh
Wanted Franchise Distributors for pharma company from Madhya Pradesh
Following are the districts vacant for franchise from Madhya Pradesh
Following are the districts vacant for franchise from Madhya Pradesh
| Bhopal |
| Raisen |
| Rajgarh |
| Sehore |
| Vidisha |
| Ashoknagar |
| Shivpuri |
| Datia |
| Guna |
| Gwalior |
| Morena |
| Sheopur |
| Bhind |
| Alirajpur |
| Barwani |
| Dhar |
| Indore |
| Jhabua |
| Khandwa (East Nimar) |
| Khargone (West Nimar) |
| Balaghat |
| Chhindwara |
| Jabalpur |
| Katni |
| Mandla |
| Narsinghpur |
| Seoni |
| Betul |
| Harda |
| Hoshangabad |
| Rewa |
| Satna |
| Sidhi |
| Singrauli |
| Chhatarpur |
| Damoh |
| Panna |
| Sagar |
| Tikamgarh |
| Anuppur |
| Dindori |
| Shahdol |
| Umaria |
| Dewas |
| Mandsaur |
| Neemuch |
| Ratlam |
| Shajapur |
| Ujjain |
Wanted Franchise or PCD Distributors for pharma company from Uttar Pradesh
Wanted Franchise Distributors for pharma company from Uttar Pradesh
Following are the districts vacant for franchise from Uttar Pradesh
Following are the districts vacant for franchise from Uttar Pradesh
| Agra |
| Allahabad |
| Aligarh |
| Ambedkar Nagar |
| Auraiya |
| Azamgarh |
| Barabanki |
| Bagpat |
| Bahraich |
| Bijnor |
| Ballia |
| Banda District |
| Kanpur Nagar |
| Kanshi Ram Nagar |
| Kaushambi |
| Kushinagar |
| Lalitpur |
| Lakhimpur Kheri |
| Mau |
| Meerut |
| Maharajganj |
| Mahoba |
| Mirzapur |
| Moradabad |
| Mainpuri |
| Mathura |
| Muzaffarnagar |
| Pilibhit |
| Pratapgarh |
| Rampur |
| Rae Bareli |
| Saharanpur |
| Sitapur |
| Shahjahanpur |
| Sant Kabir Nagar |
| Siddharthnagar |
| Sonbhadra |
| Sultanpur |
| Shravasti |
| Unnao |
| Varanasi |
| Balrampur |
| Basti |
| Bulandshahr |
| Chandauli |
| Chitrakoot |
| Deoria |
| Etah |
| Etawah |
| Firozabad |
| Farrukhabad |
| Fatehpur |
| Faizabad |
| Gautam Buddha Nagar |
| Gonda |
| Ghazipur |
| Gorkakhpur |
| Ghaziabad |
| Hamirpur |
| Hardoi |
| Mahamaya Nagar |
| Jhansi |
| Jalaun |
| Jyotiba Phule Nagar |
| Jaunpur District |
| Kanpur Dehat |
| Kannauj |
Wanted Franchise or PCD Distributors for pharma company from Andhra Pradesh
Wanted Franchise Distributors for pharma company from Andhra Pradesh
Following are the districts vacant for franchise from Andhra Pradesh
Following are the districts vacant for franchise from Andhra Pradesh
| Anantapur |
| Chittoor |
| YSR District/Kadapa District |
| East Godavari |
| Guntur |
| Hyderabad |
| Khammam |
| Krishna |
| Mahbubnagar |
| Medak |
| Nalgonda |
| Potti Sri Ramulu/Nellore |
| Rangareddi |
| Srikakulam |
| Visakhapatnam |
| Vijayanagaram |
| Warangal |
| West Godavari |
Wanted Franchise or PCD Distributors for pharma company from Rajasthan
Wanted Franchise Distributors for pharma company from Rajasthan
Following are the districts vacant for franchise from Rajasthan
Following are the districts vacant for franchise from Rajasthan
| Ajmer |
| Hanumangarh |
| Pali |
| Alwar |
| Jaipur |
| Pratapgarh |
| Banswara |
| Jaisalme |
| Rajsamand |
| Baran |
| Jalor |
| Sawai Madhopur |
| Barmer |
| Jhalawar |
| Sikar |
| Bharatpur |
| Jhunjhunu |
| Sirohi |
| Bhilwara |
| Jodhpur |
| Sri Ganganagar |
| Bundi |
| Karauli |
| Tonk |
| Chittorgarh |
| Kota |
| Udaipur |
| Churu |
| Dausa |
| Dholpur |
Wanted Franchise or PCD Distributors for pharma company from Gujarat
Wanted Franchise Distributors for pharma company from Gujarat
Following are the districts vacant for franchise from Gujarat
Following are the districts vacant for franchise from Gujarat
| Ahmedabad |
| Amreli |
| Anand |
| Barauch |
| Bhavnagar |
| Dahod |
| Gandhinagar |
| Jamnagar |
| Mehsana |
| Narmada |
| Navsari |
| Panch Mahal |
| Patan |
| Rajkot |
| Sabar Kantha |
| Surat |
| Surendranagar |
| The Dangs |
| Vadodara |
| Valsad |
| Junagadh |
| Kheda |
| kachchh
|
Wanted Franchise or PCD Distributors for pharma company from Kerala
Wanted Franchise Distributors for pharma company from Kerala
Following are the district vacant for franchise from Kerala
Following are the district vacant for franchise from Kerala
| Alappuzha |
| Ernakulam |
| Idukki |
| Kannur |
| Kasaragod |
| Kozhikode |
| Palakkad |
| Pathanamthitta |
| Thrissur |
| Thiruvananthapuram |
| Wayanad |
Wanted Franchise or PCD Distributors for pharma company from Karnataka
Wanted Franchise Distributors for pharma company from Karnataka
Following are the districts vacant for Franchise in Karnataka
Following are the districts vacant for Franchise in Karnataka
|
Bangalore Urban
|
| Bangalore Rural |
| Belgaum |
| Bellary |
| Bidar |
| Chamarajanagar |
| Chikballapur |
| Chikmagalur |
| Dakshina Kannada |
| Davanagere |
| Dharwad |
| Gadag |
| Gulbarga |
| Hassan |
| Haveri |
| Kodagu |
| Koppal |
| Mandya |
| Mysore |
| Raichur |
| Ramanagara |
| Shimoga |
| Tumkur |
| Udupi |
| Uttara Kannada |
| Yadgir |
Wanted Franchise or PCD Distributors for pharma company from Maharashtra
Wanted Franchise Distributors for pharma company from Maharashtra
Districts in Maharashtra vacant for franchise
Districts in Maharashtra vacant for franchise
| Yavatmal |
| Jalgaon |
| Chandrapur |
| Akola |
| Jalna |
| Dhule |
| Amravati |
| Kolhapur |
| Wardha |
| Aurangabad |
| Latur |
| Washim |
| Beed |
| Nandurbar |
| Bhandara |
| Nashik |
| Buldhana |
| Osmanabad |
| Gadchiroli |
| Gondia |
The need to bring some control in the misuse of brands in pharmaceutical industry
Multiplicity of brands in pharmaceutical industry has been a matter of concern for the regulatory authorities in the country for some time as they often lead to confusion and prescription errors amongst the medical practitioners. Although the practice of using same brand name for a particular pharmaceutical product by different companies is rather rare, pharma companies do use variants of an established brand name to confuse the practitioners and patients. Usually medium and small drug units are found to indulge in this unethical practice in small towns to take advantage of the goodwill created by an established brand over a period of time. Misbranding is another unethical practice amongst the pharma companies.
It is a dubious way of exploiting an established brand name for a totally different product. Two cases of misbranding that occurred some years ago were that of Disprin Plus of Reckitt Benckiser and Aspro Plus of Nicholas Piramal. Disprin and Aspro were two old and well established aspirin brands in Indian pharmaceutical market belonging to these companies.
They discontinued these products but launched Disprin Plus and Aspro Plus with paracetamol as the main ingredient to take advantage of the brand equity of Dispirin and Aspro. Such cases of misbranding can endanger lives of patients as most of them may not check the change of the ingredient in a product.
It is a dubious way of exploiting an established brand name for a totally different product. Two cases of misbranding that occurred some years ago were that of Disprin Plus of Reckitt Benckiser and Aspro Plus of Nicholas Piramal. Disprin and Aspro were two old and well established aspirin brands in Indian pharmaceutical market belonging to these companies.
They discontinued these products but launched Disprin Plus and Aspro Plus with paracetamol as the main ingredient to take advantage of the brand equity of Dispirin and Aspro. Such cases of misbranding can endanger lives of patients as most of them may not check the change of the ingredient in a product.
The need to bring some control in the misuse of brands in pharmaceutical industry has been long felt by the authorities but no effective action was ever taken by the health ministry or the chemicals ministry so far. The Supreme Court had issued an order around 10 years ago directing the government to develop a proper registration system for drug brands in coordination with drug regulatory authorities and the trademark office to prevent the confusion. But, nothing has been done by the concerned ministries after the order.
Now last week, a leading financial daily reported that the government had held preliminary discussions over the issue with a few industry stakeholders. What is to be first realized is that the Indian pharmaceutical market has nearly one lakh brands although drugs approved for marketing are around 600. This is too large a number. The number of brands must be multiplying every day as the product licenses are being issued drug control authorities in 28 states with no coordination.
The Central government has no idea about what is the actual number of brands floating in the market and their compositions. Ideally a proper audit of pharmaceutical products circulating in the market should be undertaken first and then take steps to weed out undesirable brands from the market. This may not be an easy task but needs to be done. Establishing a centralized database of brands and streamlining the issue of brands can then be done with proper coordination and support of state drug authorities.
Now last week, a leading financial daily reported that the government had held preliminary discussions over the issue with a few industry stakeholders. What is to be first realized is that the Indian pharmaceutical market has nearly one lakh brands although drugs approved for marketing are around 600. This is too large a number. The number of brands must be multiplying every day as the product licenses are being issued drug control authorities in 28 states with no coordination.
The Central government has no idea about what is the actual number of brands floating in the market and their compositions. Ideally a proper audit of pharmaceutical products circulating in the market should be undertaken first and then take steps to weed out undesirable brands from the market. This may not be an easy task but needs to be done. Establishing a centralized database of brands and streamlining the issue of brands can then be done with proper coordination and support of state drug authorities.
In Mumbai has made cutting of tablet strips mandatory.
A recent circular issued by the Food and Drug Administration, Maharashtra to retail chemists in Mumbai has made cutting of tablet strips mandatory. The circular directed the chemists that strips should be cut if the customer so desires. In fact, most of the chemists in the country are indulging in this practice for several years now.
Therefore, the rationale to issue such a circular is not very clear. What is actually required is to curb this practice in the interest of the consumers. It is possible that some poor patients may ask for strip cutting if the prescribed drug is an expensive one. But that is to be discouraged by the pharmacists at the counter in the interest of the patient safety as it could lead to under dosing and consequent in effectiveness of the drug. Incorrect and inadequate dosage of medicine by the patients is one of the main reasons for the recurrence of diseases among the poor. As such the strip cutting is not a desirable practice as that can lead to sale of expired drugs to unsuspecting and illiterate customers. At a time when some of the drug companies are colluding with retail chemists to sell expired drugs, strip cutting can actually help such unethical practices to flourish. It is obvious that when the strips are cut, the ingredient details, expiry date and batch numbers may not be there on the cut portion of the strip. This could be dangerous to patients.
Therefore, the rationale to issue such a circular is not very clear. What is actually required is to curb this practice in the interest of the consumers. It is possible that some poor patients may ask for strip cutting if the prescribed drug is an expensive one. But that is to be discouraged by the pharmacists at the counter in the interest of the patient safety as it could lead to under dosing and consequent in effectiveness of the drug. Incorrect and inadequate dosage of medicine by the patients is one of the main reasons for the recurrence of diseases among the poor. As such the strip cutting is not a desirable practice as that can lead to sale of expired drugs to unsuspecting and illiterate customers. At a time when some of the drug companies are colluding with retail chemists to sell expired drugs, strip cutting can actually help such unethical practices to flourish. It is obvious that when the strips are cut, the ingredient details, expiry date and batch numbers may not be there on the cut portion of the strip. This could be dangerous to patients.
Although Maharashtra FDA directed the chemists in the state in this regard, there is a lot of confusion on the issue amongst the pharmacist community including amongst regulatory officials. Indian Pharmaceutical Association, the national body of pharmacists in the country has alreadytaken objection to idea of legalising strip cutting. It has informed the DCGI that there is no
clear-cut provisions in the law whether strip cutting is allowed or not and regulatory officials have different views on the matter.
IPA has rightfully urged the DCGI that the issue should be included in the agenda of the next meeting of the Drug Technical Advisory Body for discussion and appropriate action. Earlier pharmaceutical companies used to sell almost all drugs belonging to different therapeutic categories in strips of 10. Marketing of tablets in multiple strip sizes and different strength developed over the years as the drug companies wanted to escape price control. Today, many pharmaceutical companies including reputed ones have strip sizes of 6 to 10 and 15 to 30.
In some cases, there are even strips of 30, 40 and 50. Such huge sizes of strips can certainly create a chaotic situation and some discipline needs to be brought in. A rationalization of strip sizes is necessary based on the therapeutic value of the drug, dosing and cost of medicine.
IPA has rightfully urged the DCGI that the issue should be included in the agenda of the next meeting of the Drug Technical Advisory Body for discussion and appropriate action. Earlier pharmaceutical companies used to sell almost all drugs belonging to different therapeutic categories in strips of 10. Marketing of tablets in multiple strip sizes and different strength developed over the years as the drug companies wanted to escape price control. Today, many pharmaceutical companies including reputed ones have strip sizes of 6 to 10 and 15 to 30.
In some cases, there are even strips of 30, 40 and 50. Such huge sizes of strips can certainly create a chaotic situation and some discipline needs to be brought in. A rationalization of strip sizes is necessary based on the therapeutic value of the drug, dosing and cost of medicine.
Subscribe to:
Posts (Atom)
Activa backs Support My School Campaign
Donate to support
